F-15,599
F-15,599 is a psychedelic drug that was first synthesized in the late 20th century. It is a member of the phenethylamine class of compounds and is known for its potent hallucinogenic effects.
History[edit | edit source]
F-15,599 was first synthesized in the 1990s by a team of chemists led by David E. Nichols at Purdue University. The compound was created as part of a larger project to develop new psychoactive drugs for use in psychiatric research.
Chemistry[edit | edit source]
F-15,599 is a phenethylamine, a class of compounds that includes many psychoactive drugs. It is structurally related to other psychedelic phenethylamines such as mescaline and 2C-B. The compound is a full agonist at the 5-HT2A receptor, which is thought to be primarily responsible for its hallucinogenic effects.
Effects[edit | edit source]
The effects of F-15,599 are similar to those of other psychedelic drugs. Users report intense visual hallucinations, altered thought processes, and a heightened sense of empathy. The drug's effects can last for several hours, and are often followed by a period of introspection and afterglow.
Legal status[edit | edit source]
As of 2021, F-15,599 is not specifically controlled in most countries, but its possession and sale may be illegal under analogue laws. In the United States, for example, it is considered a Schedule I drug under the Federal Analogue Act.
See also[edit | edit source]
- Psychedelic drug
- Phenethylamine
- David E. Nichols
- Purdue University
- 5-HT2A receptor
- Federal Analogue Act
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD